219 related articles for article (PubMed ID: 20023895)
1. The mechanism of action of platinum anticancer agents--what do we really know about it?
Gibson D
Dalton Trans; 2009 Dec; (48):10681-9. PubMed ID: 20023895
[TBL] [Abstract][Full Text] [Related]
2. Dalton Transactions themed issue on metal anticancer compounds.
Sadler PJ
Dalton Trans; 2009 Dec; (48):10647. PubMed ID: 20023890
[No Abstract] [Full Text] [Related]
3. The Midas touch in cancer chemotherapy: from platinum- to gold-dithiocarbamato complexes.
Ronconi L; Fregona D
Dalton Trans; 2009 Dec; (48):10670-80. PubMed ID: 20023894
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, characterization, in vitro antitumoral investigations and interaction with plasmid pBR322 DNA of R2eddp-platinum(IV) complexes (R = Et, n-Pr).
Kaluderović GN; Kommera H; Schwieger S; Paethanom A; Kunze M; Schmidt H; Paschke R; Steinborn D
Dalton Trans; 2009 Dec; (48):10720-6. PubMed ID: 20023900
[TBL] [Abstract][Full Text] [Related]
5. Synthesis, characterization, and cytotoxicity of dinuclear platinum-bisphosphonate complexes to be used as prodrugs in the local treatment of bone tumours.
Margiotta N; Ostuni R; Gandin V; Marzano C; Piccinonna S; Natile G
Dalton Trans; 2009 Dec; (48):10904-13. PubMed ID: 20023921
[TBL] [Abstract][Full Text] [Related]
6. Fast cleavage of a diselenide induced by a platinum(II)-methionine complex and its biological implications.
Liu Q; Wang X; Yang X; Liang X; Guo Z
J Inorg Biochem; 2010 Nov; 104(11):1178-84. PubMed ID: 20705343
[TBL] [Abstract][Full Text] [Related]
7. Substituted beta-cyclodextrin and calix[4]arene as encapsulatory vehicles for platinum(II)-based DNA intercalators.
Krause-Heuer AM; Wheate NJ; Tilby MJ; Pearson DG; Ottley CJ; Aldrich-Wright JR
Inorg Chem; 2008 Aug; 47(15):6880-8. PubMed ID: 18597414
[TBL] [Abstract][Full Text] [Related]
8. On the many roles of NH3 ligands in mono- and multinuclear complexes of platinum.
Sanz Miguel PJ; Roitzsch M; Yin L; Lax PM; Holland L; Krizanovic O; Lutterbeck M; Schürmann M; Fusch EC; Lippert B
Dalton Trans; 2009 Dec; (48):10774-86. PubMed ID: 20023907
[TBL] [Abstract][Full Text] [Related]
9. Chemistry and biological activity of platinum amidine complexes.
Michelin RA; Sgarbossa P; Sbovata SM; Gandin V; Marzano C; Bertani R
ChemMedChem; 2011 Jul; 6(7):1172-83. PubMed ID: 21630470
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of platinum-ethacrynic acid conjugates in the treatment of mesothelioma.
Zanellato I; Bonarrigo I; Sardi M; Alessio M; Gabano E; Ravera M; Osella D
ChemMedChem; 2011 Dec; 6(12):2287-93. PubMed ID: 22025407
[TBL] [Abstract][Full Text] [Related]
11. What do we know about the reduction of Pt(IV) pro-drugs?
Wexselblatt E; Gibson D
J Inorg Biochem; 2012 Dec; 117():220-9. PubMed ID: 22877926
[TBL] [Abstract][Full Text] [Related]
12. Anticancer activity of opened arene ruthenium metalla-assemblies.
Barry NP; Zava O; Furrer J; Dyson PJ; Therrien B
Dalton Trans; 2010 Jun; 39(22):5272-7. PubMed ID: 20442944
[TBL] [Abstract][Full Text] [Related]
13. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.
Pantoja E; Gallipoli A; van Zutphen S; Komeda S; Reddy D; Jaganyi D; Lutz M; Tooke DM; Spek AL; Navarro-Ranninger C; Reedijk J
J Inorg Biochem; 2006 Dec; 100(12):1955-64. PubMed ID: 17083978
[TBL] [Abstract][Full Text] [Related]
14. Inelastic neutron scattering study of Pt(II) complexes displaying anticancer properties.
de Carvalho LA; Marques MP; Martin C; Parker SF; Tomkinson J
Chemphyschem; 2011 May; 12(7):1334-41. PubMed ID: 21523878
[TBL] [Abstract][Full Text] [Related]
15. Insights into the mechanism of action and cellular targets of ruthenium complexes from NMR spectroscopy.
Giannini F; Paul LE; Furrer J
Chimia (Aarau); 2012; 66(10):775-80. PubMed ID: 23146264
[TBL] [Abstract][Full Text] [Related]
16. An androgenic steroid delivery vector that imparts activity to a non-conventional platinum(II) metallo-drug.
Huxley M; Sanchez-Cano C; Browning MJ; Navarro-Ranninger C; Quiroga AG; Rodger A; Hannon MJ
Dalton Trans; 2010 Dec; 39(47):11353-64. PubMed ID: 21031218
[TBL] [Abstract][Full Text] [Related]
17. A Cytostatic Ruthenium(II)-Platinum(II) Bis(terpyridyl) Anticancer Complex That Blocks Entry into S Phase by Up-regulating p27(KIP1).
Ramu V; Gill MR; Jarman PJ; Turton D; Thomas JA; Das A; Smythe C
Chemistry; 2015 Jun; 21(25):9185-97. PubMed ID: 25950156
[TBL] [Abstract][Full Text] [Related]
18. Selective aggregation of a platinum-gadolinium complex within a tumor-cell nucleus.
Crossley EL; Aitken JB; Vogt S; Harris HH; Rendina LM
Angew Chem Int Ed Engl; 2010 Feb; 49(7):1231-3. PubMed ID: 20077549
[No Abstract] [Full Text] [Related]
19. The second generation of iodido complexes: trans-[PtI2(amine)(amine')] bearing different aliphatic amines.
Parro T; Medrano MA; Cubo L; Muñoz-Galván S; Carnero A; Navarro-Ranninger C; Quiroga AG
J Inorg Biochem; 2013 Oct; 127():182-7. PubMed ID: 23688840
[TBL] [Abstract][Full Text] [Related]
20. DNA cleavage and antitumour activity of platinum(II) and copper(II) compounds derived from 4-methyl-2-N-(2-pyridylmethyl)aminophenol: spectroscopic, electrochemical and biological investigation.
Roy S; Maheswari PU; Lutz M; Spek AL; den Dulk H; Barends S; van Wezel GP; Hartl F; Reedijk J
Dalton Trans; 2009 Dec; (48):10846-60. PubMed ID: 20023915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]